1073. Predictors of Vancomycin Switch or Escalation in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection

BACKGROUND: Vancomycin (VAN) is the primary agent for the treatment methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI). VAN is frequently combined with or switched to a second anti-MRSA agent for the treatment of serious BSI because VAN monotherapy has been linked to tre...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: Lagnf, Abdalhamid M, Jorgensen, Sarah, Zasowski, Evan J, Trinh, Trang D, Bhatia, Sahil, Davis, Susan L, Rybak, Michael J
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254001/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.910
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires